Article citationsMore>>

B. E. Phillipson, D. W. Rothrock, W. E. Connor, W. S. Harris and D. R. Illingworth, “Reduction of Plasma Lipids, Lipoprotein, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia,” New England Journal of Medicine, Vol. 312, No. 19, 1985, pp. 1210-1216. doi:10.1056/NEJM198505093121902

has been cited by the following article:

• TITLE: Impact of Switch to Fosamprenavir and Addition of Lovaza® for Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy

  AUTHORS: Franco Felizarta, Anthony Scarsella, Homayoon Khanlou, Winston Young, Lisa Ross, Henry Zhao, Keith Pappa, Belinda Ha

  KEYWORDS: Fish Oil; Fosamprenavir; HIV; Hypertriglyceridemia; Lovaza; Switch; Triglycerides

  JOURNAL NAME: World Journal of AIDS, Vol.2 No.1, March 22, 2012

  ABSTRACT: Background: Managing hypertriglyceridemia in HIV-infected patients often requires multiple pharmacologic strategies. Many protease inhibitors (PIs), one of 6 classes of drugs used to treat HIV, have been associated with hypercholesterolemia and drug interactions. For this study, we examined a dual strategy to manage hypertriglyceridemia in HIV-infected patient taking PIs: 1) switching patients to fosamprenavir (FPV), a PI with fewer drug interactions, and 2) adding prescription fish oil (LOVAZA?), which has been shown to reduce triglycerides. Methods: This multicenter, 24-week study enrolled 36 patients virologically suppressed (HIV-1 RNA